Physician

David James Kaczorowski, M.D.

According to 2025 Medicare claims, David Kaczorowski, M.D. (NPI: 1780809889) practices cardiac surgery in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Allegheny, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PITTSBURGH PHYSICIANS (NPI: 1306804729; TIN: 232919472) and primary practice location at 15213-2536. Kaczorowski is affiliated with the WellSpan Population Health Services (ACO ID: A2500), participating under the MSSP model.

Kaczorowski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 31 traditional Medicare patients, billed 93 HCPCS/CPT codes, and received $52,141 in Medicare payments. The top billing code was 33533 (Coronary artery bypass using artery graft, 1 graft). Part D data shows 136 prescription claims across 41 beneficiaries totaling $3,360 in drug costs, led by Bisoprolol Fumarate (Bisoprolol Fumarate). Open Payments data shows 21 records totaling $50,083. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $161,471 to $52,141. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,220 and ending at $3,360. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$109K$217K2015 Medicare payment: $161,471 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $217,234 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $195,390 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $183,703 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $202,813 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $90,889 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $76,069 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $49,678 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $59,338 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $52,141 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015221398$161,471
2016278551$217,234
2017212584$195,390
2018118460$183,703
2019116646$202,813
202077277$90,889
202137111$76,069
20223086$49,678
202335111$59,338
20243193$52,141

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.3K$6.5K2015 Drug cost: $5,220 (USD; Tot_Drug_Cst)2016 Drug cost: $6,501 (USD; Tot_Drug_Cst)2017 Drug cost: $3,607 (USD; Tot_Drug_Cst)2019 Drug cost: $777 (USD; Tot_Drug_Cst)2021 Drug cost: $2,290 (USD; Tot_Drug_Cst)2022 Drug cost: $5,990 (USD; Tot_Drug_Cst)2023 Drug cost: $4,517 (USD; Tot_Drug_Cst)2024 Drug cost: $3,360 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201525162$5,220
201652188$6,501
20172481$3,607
2018N/RN/RN/R
2019N/R11$777
2020N/RN/RN/R
20211138$2,290
20221753$5,990
20231628$4,517
202441136$3,360

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
33533Coronary artery bypass using artery graft, 1 graft1313$1,397
33508Harvest of vein using an endoscope1414$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bisoprolol FumarateBisoprolol Fumarate11322$434
ClopidogrelClopidogrel Bisulfate171,530$322
Atorvastatin CalciumAtorvastatin Calcium13562$115
Metoprolol TartrateMetoprolol Tartrate161,332$97
MupirocinMupirocin16234$83

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.18$12,112ABIOMED
Research PaymentsReported research-related payment or transfer-of-value amount.3$37,971Upmc - Presbyterian Shadyside
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David James Kaczorowski, M.D.?

Tedicare shows public-source Medicare data for David James Kaczorowski, M.D. (NPI 1780809889), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David James Kaczorowski, M.D. have ACO affiliation data?

David James Kaczorowski, M.D. is shown with ACO affiliation data for WellSpan Population Health Services (MSSP, ACO ID A2500).

What billing organization is linked to David James Kaczorowski, M.D.?

David James Kaczorowski, M.D. is linked to UNIVERSITY OF PITTSBURGH PHYSICIANS (billing NPI 1306804729) in the available physician profile data.

Does David James Kaczorowski, M.D. have Open Payments data?

David James Kaczorowski, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.